Catalyzing Lung Cancer Research

March 2013 Scientist to Watch Emily Scott explains her work on a lung enzyme that interacts with nicotine and may serve as a drug target.

By | March 1, 2013

Read the full story.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: mlerman

mlerman

Posts: 70

March 14, 2013

Any drug they will develop to block the enzyme will have side effects. So, a better approach is to quit smoking. Mochael Lerman, M.D., Ph.D.

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  3. Most of Human Genome Nonfunctional: Study
  4. Identifying Predatory Publishers
AAAS